We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+3.38%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$540M
AUM Growth
+$16M
Cap. Flow
-$480K
Cap. Flow %
-0.09%
Top 10 Hldgs %
32.13%
Holding
156
New
7
Increased
37
Reduced
92
Closed
9

Top Buys

Rank Stock Value
1
DO
Diamond Offshore Drilling
DO
+$2.64M
2
CSCO icon
Cisco
CSCO
+$2.27M
3
GE icon
GE Aerospace
GE
+$2.18M
4
LXFR icon
Luxfer Holdings
LXFR
+$2.16M
5
ADT
ADT Corp
ADT
+$1.59M

Sector Composition

Rank Sector Weight
1 Healthcare 25.26%
2 Industrials 18.07%
3 Technology 17.7%
4 Energy 9.25%
5 Utilities 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$616B
$30.9M 5.73%
315,063
-6,658
-2% -$617K
GLW icon
2
Corning
GLW
$132B
$24.7M 4.57%
1,185,702
-98,206
-8% -$1.85M
XOM icon
3
ExxonMobil
XOM
$640B
$22.7M 4.2%
232,316
-618
-0.3% -$58.9K
EMR icon
4
Emerson Electric
EMR
$78.2B
$17.2M 3.19%
257,695
+15,490
+6% +$1.02M
KO icon
5
Coca-Cola
KO
$354B
$14.4M 2.67%
372,591
+31,609
+9% +$1.22M
INTC icon
6
Intel
INTC
$517B
$13.4M 2.49%
520,992
+6,961
+1% +$174K
PLL
7
DELISTED
PALL CORP
PLL
$13.1M 2.42%
146,301
-4,310
-3% -$365K
SLB icon
8
SLB Ltd
SLB
$71.3B
$12.8M 2.37%
131,023
-711
-0.5% -$64.3K
MRK icon
9
Merck
MRK
$315B
$12.1M 2.25%
224,281
+864
+0.4% +$44.7K
BMY icon
10
Bristol-Myers Squibb
BMY
$124B
$12.1M 2.24%
232,552
-11,170
-5% -$594K
IBM icon
11
IBM
IBM
$194B
$11.7M 2.16%
63,417
+4,210
+7% +$741K
PFE icon
12
Pfizer
PFE
$142B
$11.7M 2.16%
382,423
+24,141
+7% +$720K
GXP
13
DELISTED
Great Plains Energy Incorporated
GXP
$10.6M 1.97%
393,580
-8,620
-2% -$218K
GSK icon
14
GSK
GSK
$102B
$10.5M 1.95%
157,289
+5,004
+3% +$338K
GVA icon
15
Granite Construction
GVA
$5.5B
$10.4M 1.94%
261,692
-7,700
-3% -$276K
MSFT icon
16
Microsoft
MSFT
$2.9T
$10.3M 1.9%
250,549
-11,135
-4% -$418K
HON icon
17
Honeywell
HON
$73.8B
$8.85M 1.64%
106,146
-5,098
-5% -$422K
MMM icon
18
3M
MMM
$89B
$8.44M 1.56%
74,361
-1,294
-2% -$144K
BCE icon
19
BCE
BCE
$20B
$8.13M 1.51%
188,449
+13,850
+8% +$590K
AMGN icon
20
Amgen
AMGN
$198B
$8.08M 1.5%
65,522
-3,368
-5% -$408K
IDA icon
21
Idacorp
IDA
$8.25B
$7.66M 1.42%
138,165
-44,310
-24% -$2.37M
CSCO icon
22
Cisco
CSCO
$443B
$7.11M 1.32%
317,320
+102,887
+48% +$2.27M
EXC icon
23
Exelon
EXC
$47.8B
$7.11M 1.32%
297,014
-20,259
-6% -$426K
NVS icon
24
Novartis
NVS
$292B
$6.95M 1.29%
91,221
-4,531
-5% -$330K
DRC
25
DELISTED
DRESSER-RAND GROUP INC
DRC
$6.93M 1.28%
118,685
+15,925
+15% +$907K

Similar funds

John G. Ullman & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, John G. Ullman & Associates held 156 positions worth $540M, up 3.1% from $524M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates's Q1 2014 filing shows 7 new, 37 increased, 92 reduced and 9 closed positions. Its largest new stake was Diamond Offshore Drilling: 53,600 shares worth $2.61M. The largest sale was ZOLTEK COMPANIES INC, an estimated $3.34M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q1 2014 buy was Diamond Offshore Drilling: 53,600 shares worth $2.61M.
  • John G. Ullman & Associates added most to Cisco in Q1 2014, an estimated $2.27M increase.
  • John G. Ullman & Associates's biggest Q1 2014 reduction was Idacorp, cutting an estimated $2.37M.
  • John G. Ullman & Associates fully exited ZOLTEK COMPANIES INC in Q1 2014, selling an estimated $3.34M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $540M portfolio in Q1 2014.
  • John G. Ullman & Associates opened 7 new positions and closed 9 in Q1 2014.
  • John G. Ullman & Associates's portfolio value rose 3.1% quarter-over-quarter to $540M.

Based on John G. Ullman & Associates's 13F filing for Q1 2014, filed 7 May 2014.